Artificial Intelligence in Medicine.
Latest in FAIM
September 1, 2023
Roo from Spark Biomedical is a neurostimulation device that reduces opioid withdrawal symptoms in infants...
September 1, 2023
The Nference technology facilitates the smooth triangulation of hierarchical databases, making unstructured information computable...
September 1, 2023
CEFALY DUAL device helps alleviate pain and limitations resulting from migraines and offers an innovative solution that allows the patient not to require medication...
September 1, 2023
Considered "The superhero of AI," Demis Hassabis has proven that he possesses a mind beyond his years and an eagerness to discover the full potential of AI to solve humanity's grand challenges...
September 1, 2023
Welcome to the latest edition of the Newsletter, where we bring you the freshest updates and insights on cutting-edge advancements at the intersection of artificial intelligence and healthcare...
September 1, 2023
Interoperability is an integrative feature of digital medicine. It will take a fundamental role in healthcare-related AI, as it will be the standardized foundation for every single algorithm and structured data processed on AI worldwide...
September 1, 2023
Finland pioneers AI in healthcare with companies like Nightingale Health, Blueprint Genetics, Kaiku Health, and Popit. Their AI-driven solutions revolutionize patient care, diagnostics, cancer management, and medication adherence, enhancing outcomes and empowering individuals...
September 1, 2023
Artificial intelligence is advancing by leaps and bounds, hand in hand with robotics and its subdivisions, nanorobotics, and conversational bots, to propose real solutions for the diagnosis and treatment of diseases...
August 1, 2023
CUE1 utilize focused vibrotactile stimulation combined with cueing techniques. This innovative approach has demonstrated positive effects on the mobility and safety of users. Studies have supported the effectiveness of this combination in reducing freezing of gait episodes in Parkinson's disease...
Expert Interview
Dr. Sameer Mehta
Editor-In Chief & Founder
Sameer Mehta, MD, FACC, MBA, is a U.S. interventional cardiologist
Journal Club
Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer from Biopsy Specimens
JAMA Network Open – Oncology – May 13, 2020
SIGN UP FOR OUR NEWSLETTER
Join our subscribers list to get the latest news and updates directly in your inbox.
Our Partners
Previous
Next